UCB, Advent International and Avista Capital Partners last week announced they have entered into a definitive agreement providing for the acquisition of UCB’s U.S. specialty generics subsidiary, Kremers Urban Pharmaceuticals, by Advent and Avista.
Eli Lilly and Co. on Monday announced that its Type 2 diabetes treatment drug Trulicity (dulaglutide) , is now available in U.S. pharmacies. The drug is a once-weekly glucagon-like peptide-1 receptor agonist, and comes in a single-dose pen, which doesn't require the patient to mix, measure or handle the needle, the company said.
The Centers for Disease Control and Prevention on Friday ordered $2.7 million in personal protective equipment to increase strategic national stockpile supplies to assist U.S. hospitals caring for Ebola patients.
Mission Pharmacal Company and Europa Sports Products of Charlotte, N.C., signed an agreement for Europa to distribute Mission's Compete energy bites to fitness centers and select other retail outlets nationally.
Sandoz last week announced the launch of a generic version of cyclophosphamide injection, USP. Sandoz is launching the drug through collaboration with Jiangsu Hengrui Medicine Co., which owns the product's abbreviated new drug application.